And there are some products that are on subscription that I think would lend itself for you to create a great subscription-based product. And then further with all of the data you have what kind of applications of AI to kind of clean patterns like you said, if you have a rectal dysfunction it is a lot of times an indication of heart health.
Andrew Dudum: Thanks Ivan for the question, and congratulations as well. I think on the on the — both parts of that question were things were really excited by. So, on the subscription offering side, Yemi spoke about how these pricing changes move from a pill-based construct to a treatment-based construct. And what that allows us to do is offer more kind of membership level and subscription level pricing and value for that single price point, right? And so when you think about weight management, there’s a really holistic approach here. There is the necessity for great nutrient and great calorie intake, right? There’s the necessity to move your body right 5,000, 7,000 10,000 steps per day. There’s a physiological requirement to get great sleep.
I mean, you can be doing all of these things, but if you’re not sleeping well you will not shed those pounds. And so it is comprehensive. And I think Dr. Primark on the Wave management side of the house as been able to educate us and our outside partners have been able to inform us on kind of the necessity of all of those factors. So you should absolutely expect that over the coming quarters, you’ll see the mobile app which has increasingly become the core dominant destination for customers, expand to represent content, nutrition, tools, tracking et cetera such that we can more appropriately and holistically gets you to a great outcome. And that could be on weight management that could be on dermatology-related issues that could be on cardiovascular health, because each of these really does require a broad set of approaches.
So absolutely on the subscription and the comprehensiveness that’s something we’re really excited by and spending a lot of time investing in. And then on the AI side of the house, there’s just a tremendous amount of opportunity for us to better inform patients better educate patients ultimately get them to a better outcome. This could be on the diagnosis and treatment side of the house as we expand more personalized treatment options using AI to help providers make really, really great informed decisions about which specific treatment and which specific dose are going to result in great outcomes and that’s a little bit of what we talked about already with Med Match. But also on the post-treatment side of the house once you’ve actually started the treatment what are the things you can do to really drive better efficacy and adherence and ultimately better outcomes.
And there’s a lot of predictive abilities that we can build, and are currently building to help inform patients and get the right content in front of patients such that they can have the best outcome possible. So it’s very early days on this front, but it’s frankly I think one of the things we’re most excited about as a business because it can overarchingly improve the experience from diagnostic to treatment to eventual adherence and ultimately increase medical efficacy quite dramatically.
Ivan Feinseth: I’m excited for you, because obviously heart health and weight management — weight management and heart health go hand in hand. So this sounds like it goes up like a tremendous new platform of opportunities. So congratulations.
Andrew Dudum: Thanks, Ivan.
Operator: This will conclude today’s conference call. Thank you for joining us today. You may now disconnect.
